SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    C. A. Roberts, C. Montgomery, fNIRS suggests increased effort during executive access in ecstasy polydrug users, Psychopharmacology, 2015, 232, 9, 1571

    CrossRef

  2. 2
    Rick Doblin, George Greer, Julie Holland, Lisa Jerome, Michael C. Mithoefer, Ben Sessa, A reconsideration and response to Parrott AC (2013) “Human psychobiology of MDMA or ‘Ecstasy’: an overview of 25 years of empirical research”, Human Psychopharmacology: Clinical and Experimental, 2014, 29, 2
  3. 3
    Claire White, John Brown, Mark Edwards, Alterations to global but not local motion processing in long-term ecstasy (MDMA) users, Psychopharmacology, 2014, 231, 13, 2611

    CrossRef

  4. 4
    Lynn Taurah, Chris Chandler, Geoff Sanders, Depression, impulsiveness, sleep, and memory in past and present polydrug users of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy), Psychopharmacology, 2014, 231, 4, 737

    CrossRef

  5. 5
    Amy Emerson, Linnae Ponté, Lisa Jerome, Rick Doblin, History and Future of the Multidisciplinary Association for Psychedelic Studies (MAPS), Journal of Psychoactive Drugs, 2014, 46, 1, 27

    CrossRef

  6. 6
    Andrew C. Parrott, MDMA is certainly damaging after 25 years of empirical research: a reply and refutation of Doblin et al. (2014), Human Psychopharmacology: Clinical and Experimental, 2014, 29, 2
  7. 7
    Una D. McCann, George A. Ricaurte, The Effects of Drug Abuse on the Human Nervous System, 2014,

    CrossRef

  8. 8
    Drugs of Abuse, 2014,

    CrossRef

  9. 9
    Daniel Wagner, Benjamin Becker, Philip Koester, Euphrosyne Gouzoulis-Mayfrank, Joerg Daumann, A prospective study of learning, memory, and executive function in new MDMA users, Addiction, 2013, 108, 1
  10. 10
    Tristan J. Watkins, Vidya Raj, Junghee Lee, Mary S. Dietrich, Aize Cao, Jennifer U. Blackford, Ronald M. Salomon, Sohee Park, Margaret M. Benningfield, Christina R. Di Iorio, Ronald L. Cowan, Human ecstasy (MDMA) polydrug users have altered brain activation during semantic processing, Psychopharmacology, 2013, 227, 1, 41

    CrossRef

  11. You have free access to this content11
    Andrew C. Parrott, Human psychobiology of MDMA or ‘Ecstasy’: an overview of 25 years of empirical research, Human Psychopharmacology: Clinical and Experimental, 2013, 28, 4
  12. 12
    Andrew C. Parrott, MDMA, serotonergic neurotoxicity, and the diverse functional deficits of recreational ‘Ecstasy’ users, Neuroscience & Biobehavioral Reviews, 2013, 37, 8, 1466

    CrossRef

  13. 13
    Benjamin Becker, Daniel Wagner, Philip Koester, Katja Bender, Christoph Kabbasch, Euphrosyne Gouzoulis-Mayfrank, Jörg Daumann, Memory-related hippocampal functioning in ecstasy and amphetamine users, Psychopharmacology, 2013, 225, 4, 923

    CrossRef

  14. 14
    Rafael Guimarães dos Santos, Safety and Side Effects of Ayahuasca in Humans—An Overview Focusing on Developmental Toxicology, Journal of Psychoactive Drugs, 2013, 45, 1, 68

    CrossRef

  15. 15
    J.W. Dalley, J.P. Roiser, Dopamine, serotonin and impulsivity, Neuroscience, 2012, 215, 42

    CrossRef

  16. 16
    JACQUI RODGERS, TOM BUCHANAN, TOM HEFFERNAN, JONATHAN LING, ANDREW SCHOLEY, ‘ECSTASY USE, BY ITSELF, DOES NOT RESULT IN RESIDUAL NEUROTOXICITY’– A POWERFUL ARGUMENT?, Addiction, 2011, 106, 7
  17. 17
    P.D. Sainsbury, A.T. Kicman, R.P. Archer, L.A. King, R.A. Braithwaite, Aminoindanes—the next wave of ‘legal highs’?, Drug Testing and Analysis, 2011, 3, 7-8
  18. 18
    JOHN E. FISK, PHILIP N. MURPHY, CATHARINE MONTGOMERY, MICHELLE WAREING, COMMENT ON HALPERN ET AL. (2011), Addiction, 2011, 106, 7
  19. 19
    MICHAEL LYVERS, Commentary on Halpern et al. (2011): Strengthening the case against functionally significant serotonergic neurotoxicity in human MDMA (ecstasy) users, Addiction, 2011, 106, 4
  20. 20
    JOHN H. HALPERN, ANDREA R. SHERWOOD, JAMES I. HUDSON, STACI GRUBER, DAVID KOZIN, HARRISON G. POPE JR, REPLY TO PARROTT (2011), FISK ET AL. (2011) AND RODGERS ET AL. (2011), Addiction, 2011, 106, 7
  21. 21
    ANDREW C. PARROTT, RESIDUAL NEUROCOGNITIVE FEATURES OF ECSTASY USE: A RE-INTERPRETATION OF HALPERN ET AL. (2011) CONSISTENT WITH SEROTONERGIC NEUROTOXICITY, Addiction, 2011, 106, 7
  22. 22
    Rif S. El-Mallakh, John H. Halpern, Henry David Abraham, Substance Abuse: Hallucinogen- and MDMA-Related Disorders,